All data are based on the daily closing price as of October 22, 2024
g
GemVax&KAEL
082270.KQ
13.71 USD
-0.81
-5.58%
Overview
Last close
13.71 usd
Market cap
489.19M usd
52 week high
16.74 usd
52 week low
7.30 usd
Target price
N/A usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
12.3987
Price/Book Value
9.766
Enterprise Value
589.11M usd
EV/Revenue
12.7706
EV/EBITDA
-173.0774
Key financials
Revenue TTM
57.24M usd
Gross Profit TTM
13.54M usd
EBITDA TTM
1.67M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
138.76B usd
Net debt
N/A usd
About
GemVax&KAEL Co.,Ltd engages in the manufacturing and commercializing of resins and filters for semi-conductor and panel display production in South Korea. The company offers impregnated active carbon and inorganic adsorbent coating resins; CA filter for removing chemical pollution substances and harmful gases in semiconductor and LCD/PDP manufacturing process; adsorbent towers for air pollution prevention; and pressure facility for preventing equipment erosion within a substation; and 5aver, a fire evacuation mask. It also engages in the research and development of anti-cancer immunotherapeutic and peptide drugs; and provides RIAVAX, an immunotherapeutic peptide for the treatment of locally advanced or metastatic pancreatic cancer. The company was founded in 1998 and is headquartered in Daejeon, South Korea.